There are five upcoming IPOs on this week's IPO calendar, expected to raise a combined $239 million. Four of the five are delays from previous weeks.
The biggest name this week is Chinese e-commerce giant Wowo Ltd. (Nasdaq: WOWO). The company follows in the tremendous footsteps of Alibaba Group Holding Ltd. (NYSE: BABA), another Chinese e-commerce company that had the largest U.S. IPO of all time in September.
The other four upcoming IPOs this week include an eye treatment firm, two medical equipment providers, and a company that has developed a capsule for detecting colorectal cancer...
Five Upcoming IPOs This Week
Wowo Ltd. (Nasdaq: WOWO) is a leading e-commerce service in China. The company owns e-commerce site "55tuan," considered the "Groupon Inc. of China" by Renaissance Capital, a manager of IPO-focused ETFs. It also owns e-commerce site "WoWo Mall," mobile commerce infrastructure "WoWo Mobile," and electronic management system "WoWo EMS." Wowo posted $29 million in sales from September 2013 to September 2014. Wowo is set for a $60 million deal by selling 6 million ADSs at a $9 to $11 price range. It is valued at $384 million. The Beijing-based company will be trading American Depository Shares (ADSs) - U.S. dollar-denominated shares that disregard currency conversions in order to gain a larger investor base.
Inotek Pharmaceuticals Corp. (Nasdaq: ITEK) is a clinical-stage company that develops therapies for glaucoma and other eye diseases. It has an eye drop glaucoma treatment in phase II trials and hopes to finish phase III by 2017. Inotek plans to raise $65 million by offering 4.6 million shares at a $13 to $15 price range. According to Renaissance Capital, a manager of IPO-focused ETFs, the company pushed back its IPO twice but is now slated to go public sometime this week. Close peer Ocular Therapeutix Inc. (Nasdaq: OCUL) has soared 138% since its July 2014 opening.
Money Morning Members: Continue reading for three more upcoming IPOs this week. For those new to Money Morning, you can get the rest of this week's IPOs, plus access to all our investing content, by signing up today...
[epom key="ddec3ef33420ef7c9964a4695c349764" redirect="" sourceid="" imported="false"]
Infraredx Inc. (Nasdaq: REDX) is a medical equipment company focused on coronary artery disease. Infraredx develops catheter devices used for identifying coronary plaque. The firm will raise $56 million by selling 4 million shares at a $13 to $15 price range. It has a market valuation of $213 million. REDX stock was originally going to launch on Jan. 30, but has postponed multiple times. Renaissance Capital analysts have attributed the delays to "valid concerns over execution risk, intense competition, and the companies' need for additional capital later on."
AutoGenomics Inc. (Nasdaq: AGMX) is a molecular and genetic diagnostics company based in Vista, Calif. AutoGenomics sells genetic testing equipment to laboratories. It is set for a $45 million deal by offering 3.8 million shares at a price range of $11 to $13. The company is valued at $126 million. AGMX stock was scheduled to debut on Feb. 11, but delayed.
Check-Cap Ltd. (Nasdaq: CHEK) is an Israel-based medical company developing an ingestible imaging capsule for detecting colorectal cancer. Check-Cap will raise $13 million by offering 1.2 million shares at a $10 to $12 price range. CHEK also delayed its IPO from last week.
Investing in Upcoming IPOs can be risky - but we know how to make it profitable... IPO gains are usually reserved for traders with millions of dollars to invest. But Money Morning experts have found a way for retail investors to play the IPO market. Here's how you can see the types of gains normally reserved for the "Insiders Club"...
Follow me on Twitter: @AlexMcGuire92